Although Sln is predominantly expressed in atria, its ablation significantly increased the Ca-affinity of SERCA2a in the ventricle [34], and its downregulation by AAV treatment improved cardiac function in a Duchenne muscular dystrophy model [35]. The gene discussed is SLN; the disease is Duchenne muscular dystrophy.